Medexus Pharmaceuticals IncMedexus Pharmaceuticals IncMedexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc

No trades
See on Supercharts

Price target

2.390.00 0.00%
The 6 analysts offering 1 year price forecasts for MEDXF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to MEDXF in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

MEDXF EPS for the last quarter is −0.01 USD despite the estimation of −0.02 USD. In the next quarter EPS is expected to reach 0.01 USD. Track more of Medexus Pharmaceuticals Inc financials and stay on top of what is up with the company.
In the next quarter Medexus Pharmaceuticals Inc revenue is expected to reach ‪28.38 M‬ USD. Check out Medexus Pharmaceuticals Inc revenue and earnings and make informed decisions.
According to analysts, MEDXF price target is 2.39 USD with a max estimate of 4.30 USD and a min estimate of 1.49 USD. Check if this forecast comes true in a year, meanwhile watch Medexus Pharmaceuticals Inc stock price chart and keep track of the current situation with MEDXF news and stock market news.
We've gathered opinions of 6 analysts rating MEDXF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.